The Canadian Cohort Obstructive Lung Disease

UnknownOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
COPDChronic Obstructive Pulmonary Disease
Trial Locations (9)

T2N 4N1

Health Sciences Centre, Calgary

V6Z 1Y6

St-Paul's Hospital, Vancouver

B3H 3A7

Halifax Infirmary, Halifax

K7L 2V6

Kingston General Hospital, Kingston

K1H 8L6

Ottawa Hospital General, Ottawa

M5T 2S8

University of Toronto, Toronto

H2X 2P4

Montreal Chest Institute, Montreal

S7N 0W8

Royal University Hospital, Saskatoon

G1V 4G5

Institut universitaire de cardiologie et de pneumologie de Québec, Québec

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Novartis

INDUSTRY

collaborator

Takeda

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Almirall, SAS

INDUSTRY

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER